{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:12:47Z","timestamp":1780474367872,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T00:00:00Z","timestamp":1323820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s11914-011-0083-y","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T04:34:38Z","timestamp":1323750878000},"page":"48-55","source":"Crossref","is-referenced-by-count":51,"title":["Osteoporosis After Transplantation"],"prefix":"10.1007","volume":"10","author":[{"given":"Carolina A. Moreira","family":"Kulak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Z. Cochenski","family":"Borba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Kulak","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melani Ribeiro","family":"Cust\u00f3dio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"issue":"2","key":"83_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0004-27302010000200009","volume":"54","author":"CA Kulak","year":"2010","unstructured":"Kulak CA, Borba VZ, Kulak Junior J, Campos DJ, Shane E. Post-transplantation osteoporosis. Arq Bras Endocrinol Metabol. 2010;54(2):143\u20139.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"83_CR2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ecl.2007.07.008","volume":"36","author":"E Stein","year":"2007","unstructured":"Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinol Metab Clin North Am. 2007;36(4):937\u201363. viii.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"83_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.5650110102","volume":"11","author":"S Epstein","year":"1996","unstructured":"Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res. 1996;11(1):1\u20137.","journal-title":"J Bone Miner Res."},{"issue":"8","key":"83_CR4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","volume":"325","author":"BA Julian","year":"1991","unstructured":"Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med. 1991;325(8):544\u201350.","journal-title":"N Engl J Med."},{"key":"83_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.2002.tb04204.x","volume":"966","author":"E Canalis","year":"2002","unstructured":"Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci. 2002;966:73\u201381.","journal-title":"Ann N Y Acad Sci."},{"issue":"2","key":"83_CR6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","volume":"102","author":"RS Weinstein","year":"1998","unstructured":"Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102(2):274\u201382.","journal-title":"J Clin Invest."},{"issue":"5","key":"83_CR7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/jcem-40-5-774","volume":"40","author":"M Sakakura","year":"1975","unstructured":"Sakakura M, Takebe K, Nakagawa S. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab. 1975;40(5):774\u20139.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"83_CR8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0026-0495(83)90221-4","volume":"32","author":"Y Suzuki","year":"1983","unstructured":"Suzuki Y, Ichikawa Y, Saito E, Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism. 1983;32(2):151\u20136.","journal-title":"Metabolism."},{"issue":"4","key":"83_CR9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2265.2008.03212.x","volume":"69","author":"GM Peeters","year":"2008","unstructured":"Peeters GM, van Schoor NM, van Rossum EF, Visser M, Lips P. The relationship between cortisol, muscle mass and muscle strength in older persons and the role of genetic variations in the glucocorticoid receptor. Clin Endocrinol (Oxf). 2008;69(4):673\u201382.","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"83_CR10","doi-asserted-by":"crossref","first-page":"F285","DOI":"10.1152\/ajprenal.00415.2005","volume":"292","author":"L Sun","year":"2007","unstructured":"Sun L, Peng Y, Zaidi N, Zhu LL, Iqbal J, Yamoah K, et al. Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. Am J Physiol Renal Physiol. 2007;292(1):F285\u201391.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"8","key":"83_CR11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.TP.0000137937.44703.42","volume":"78","author":"MA Josephson","year":"2004","unstructured":"Josephson MA, Schumm LP, Chiu MY, Marshall C, Thistlethwaite JR, Sprague SM. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation. 2004;78(8):1233\u20136.","journal-title":"Transplantation."},{"issue":"1","key":"83_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-0012.1995.tb00291.x","volume":"9","author":"HD McIntyre","year":"1995","unstructured":"McIntyre HD, Menzies B, Rigby R, Perry-Keene DA, Hawley CM, Hardie IR. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens. Clin Transplant. 1995;9(1):20\u20134.","journal-title":"Clin Transplant."},{"issue":"2\u20133","key":"83_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1432-2277.2002.tb00133.x","volume":"15","author":"E Goffin","year":"2002","unstructured":"Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, et al. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. Transpl Int. 2002;15(2\u20133):73\u201380.","journal-title":"Transpl Int."},{"issue":"2","key":"83_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02678145","volume":"68","author":"A Monegal","year":"2001","unstructured":"Monegal A, Navasa M, Guanabens N, Peris P, Pons F, de Osaba MJ Martinez, et al. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int. 2001;68(2):83\u20136.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"83_CR15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","volume":"333","author":"KA Hruska","year":"1995","unstructured":"Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med. 1995;333(3):166\u201374.","journal-title":"N Engl J Med."},{"issue":"5","key":"83_CR16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","volume":"19","author":"P Evenepoel","year":"2004","unstructured":"Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant. 2004;19(5):1281\u20137.","journal-title":"Nephrol Dial Transplant."},{"issue":"11","key":"83_CR17","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","volume":"15","author":"JL Reynolds","year":"2004","unstructured":"Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15(11):2857\u201367.","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"83_CR18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s004670050772","volume":"14","author":"PC Koch Nogueira","year":"2000","unstructured":"Koch Nogueira PC, David L, Cochat P. Evolution of secondary hyperparathyroidism after renal transplantation. Pediatr Nephrol. 2000;14(4):342\u20136.","journal-title":"Pediatr Nephrol"},{"issue":"2\u20135","key":"83_CR19","first-page":"166","volume":"18","author":"JT Kwan","year":"1992","unstructured":"Kwan JT, Almond MK, Evans K, Cunningham J. Changes in total body bone mineral content and regional bone mineral density in renal patients following renal transplantation. Miner Electrolyte Metab. 1992;18(2\u20135):166\u20138.","journal-title":"Miner Electrolyte Metab."},{"issue":"9","key":"83_CR20","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/00007890-199905150-00004","volume":"67","author":"U Nisbeth","year":"1999","unstructured":"Nisbeth U, Lindh E, Ljunghall S, Backman U, Fellstrom B. Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation. 1999;67(9):1218\u201322.","journal-title":"Transplantation."},{"issue":"7","key":"83_CR21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1047-2797(01)00226-5","volume":"11","author":"KC Abbott","year":"2001","unstructured":"Abbott KC, Oglesby RJ, Hypolite IO, Kirk AD, Ko CW, Welch PG, et al. Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol. 2001;11(7):450\u20137.","journal-title":"Ann Epidemiol."},{"issue":"Suppl 2","key":"83_CR22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/2047-783X-15-S2-68","volume":"15","author":"D Jastrzebski","year":"2010","unstructured":"Jastrzebski D, Lutogniewska W, Ochman M, Margas A, Kowalski K, Wyrwol J, et al. Osteoporosis in patients referred for lung transplantation. Eur J Med Res. 2010;15 Suppl 2:68\u201371.","journal-title":"Eur J Med Res."},{"issue":"11","key":"83_CR23","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00198-009-0890-5","volume":"20","author":"CB Franco","year":"2009","unstructured":"Franco CB, Paz-Filho G, Gomes PE, Nascimento VB, Kulak CA, Boguszewski CL, et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int. 2009;20(11):1881\u20137.","journal-title":"Osteoporos Int."},{"issue":"(25","key":"83_CR24","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/jbmr.88","volume":"9","author":"CABV Kulak","year":"2010","unstructured":"\u2022\u2022 Kulak CA BV, Jorgetti, V, Dos Reis LM, Liu XS, Kimmel DB, Kulak J Jr, Rabelo LM, Zhou H, Guo XE, Bilezikian JP, Boguszewski CL, Dempster DW. Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease. J Bone Miner Res. 2010;9(25):1931\u201340. In this study it was demonstrated that COPD patients present with microarchitecture deterioration before transplant, and it was related to the amount of smoking.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"83_CR25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.117.2.476","volume":"117","author":"A Spira","year":"2000","unstructured":"Spira A, Gutierrez C, Chaparro C, Hutcheon MA, Chan CK. Osteoporosis and lung transplantation: a prospective study. Chest. 2000;117(2):476\u201381.","journal-title":"Chest."},{"issue":"11","key":"83_CR26","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1183\/09031936.96.09112378","volume":"9","author":"SL Ferrari","year":"1996","unstructured":"Ferrari SL, Nicod LP, Hamacher J, Spiliopoulos A, Slosman DO, Rochat T, et al. Osteoporosis in patients undergoing lung transplantation. Eur Respir J. 1996;9(11):2378\u201382.","journal-title":"Eur Respir J."},{"issue":"3","key":"83_CR27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9343(96)00155-6","volume":"101","author":"E Shane","year":"1996","unstructured":"Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med. 1996;101(3):262\u20139.","journal-title":"Am J Med."},{"issue":"6","key":"83_CR28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1399-0012.2009.00989.x","volume":"23","author":"EM Stein","year":"2009","unstructured":"\u2022 Stein EM, Cohen A, Freeby M, Rogers H, Kokolus S, Scott V, et al. Severe vitamin D deficiency among heart and liver transplant recipients. Clin Transplant. 2009 Nov-Dec;23(6):861\u20135. This study demonstrates that vitamin D deficiency is highly prevalent among heart and liver transplant recipients. Ninety-one percent had levels below 75\u00a0nmol\/L, with the liver recipient patients at greatest risk.","journal-title":"Clin Transplant"},{"issue":"1","key":"83_CR29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/TP.0b013e31821cdeef","volume":"92","author":"L Dalle Carbonare","year":"2011","unstructured":"\u2022\u2022 Dalle Carbonare L, Zanatta M, Braga V, Sella S, Vilei MT, Feltrin G, et al. Densitometric threshold and vertebral fractures in heart transplant patients. Transplantation. 2011 Jul 15;92(1):106\u201311. This is a cross-sectional study in 180 heart transplant patients showing that standard densitometric criteria were unreliable to identify bone fragility.","journal-title":"Transplantation"},{"issue":"5","key":"83_CR30","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1210\/jc.81.5.1740","volume":"81","author":"E Shane","year":"1996","unstructured":"Shane E, Rivas M, Staron RB, Silverberg SJ, Seibel MJ, Kuiper J, et al. Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab. 1996;81(5):1740\u20136.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"83_CR31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1399-3046.2009.01244.x","volume":"14","author":"R Sachdeva","year":"2010","unstructured":"Sachdeva R, Soora R, Bryant JC, Seibert JJ, Blaszak RT, Frazier EA. Bone mineral status in pediatric heart transplant recipients: a retrospective observational study of an \u201cat risk\u201d cohort. Pediatr Transplant. 2010;14(3):383\u20137.","journal-title":"Pediatr Transplant."},{"issue":"1","key":"83_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bmt.2010.198","volume":"46","author":"BL McClune","year":"2011","unstructured":"\u2022 McClune BL, Polgreen LE, Burmeister LA, Blaes AH, Mulrooney DA, Burns LJ, et al. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients. Bone Marrow Transplant. 2011;Jan;46(1):1\u20139. In this paper, the authors recommend screening all adult allogeneic and autologous hematopoietic cell transplantation patients with DXA 1\u00a0year after transplantation as well as pediatric patients at risk for bone loss.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"83_CR33","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2003-09-3081","volume":"103","author":"CM Schulte","year":"2004","unstructured":"Schulte CM, Beelen DW. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood. 2004;103(10):3635\u201343.","journal-title":"Blood."},{"issue":"2","key":"83_CR34","first-page":"200","volume":"266","author":"RS Leeuwin","year":"1983","unstructured":"Leeuwin RS, Njio KD, Belling GA, van den Hoven S. Glucocorticoid-induced changes in synaptic vesicles of rat phrenic nerve terminals. Arch Int Pharmacodyn Ther. 1983;266(2):200\u20137.","journal-title":"Arch Int Pharmacodyn Ther."},{"issue":"12","key":"83_CR35","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/bmt.2009.70","volume":"43","author":"GA Faulhaber","year":"2009","unstructured":"\u2022 Faulhaber GA, Premaor MO, Moser Filho HL, Silla LM, Furlanetto TW. Low bone mineral density is associated with insulin resistance in bone marrow transplant subjects. Bone Marrow Transplant. 2009 Jun;43(12):953\u20137. This study shows that insulin resistance, low vitamin D, and ferritin levels were associated with low bone mass in bone marrow recipient patients.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"83_CR36","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.bmt.1704448","volume":"33","author":"M Kreutz","year":"2004","unstructured":"Kreutz M, Eissner G, Hahn J, Andreesen R, Drobnik W, Holler E. Variations in 1 alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;33(8):871\u20133.","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"83_CR37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/jlts.2003.50044","volume":"9","author":"JE Compston","year":"2003","unstructured":"Compston JE. Osteoporosis after liver transplantation. Liver Transpl. 2003;9(4):321\u201330.","journal-title":"Liver Transpl."},{"issue":"1","key":"83_CR38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-8278(02)00100-9","volume":"37","author":"M Ninkovic","year":"2002","unstructured":"Ninkovic M, Love S, Tom BD, Bearcroft PW, Alexander GJ, Compston JE. Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J Hepatol. 2002;37(1):93\u2013100.","journal-title":"J Hepatol."},{"issue":"6","key":"83_CR39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s001980170094","volume":"12","author":"A Monegal","year":"2001","unstructured":"Monegal A, Navasa M, Guanabens N, Peris P, Pons F, de Osaba MJ Martinez, et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int. 2001;12(6):484\u201392.","journal-title":"Osteoporos Int"},{"issue":"4","key":"83_CR40","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.transproceed.2011.02.027","volume":"43","author":"LF Baccaro","year":"2011","unstructured":"\u2022 Baccaro LF, Boin IF, Pedro AO, Costa-Paiva L, Leal AL, Ramos CD, et al. Decrease in bone mass in women after liver transplantation: associated factors. Transplant Proc. 2011 May;43(4):1351\u20136. This study shows that estrogen prevents bone loss in premenopausal women after transplantation.","journal-title":"Transplant Proc"},{"issue":"3","key":"83_CR41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1399-0012.2006.00497.x","volume":"20","author":"E Fabrega","year":"2006","unstructured":"Fabrega E, Orive A, Garcia-Unzueta M, Amado JA, Casafont F, Pons-Romero F. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation. Clin Transplant. 2006;20(3):383\u20138.","journal-title":"Clin Transplant"},{"issue":"2","key":"83_CR42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1210\/jc.2005-0547","volume":"91","author":"K Querings","year":"2006","unstructured":"Querings K, Girndt M, Geisel J, Georg T, Tilgen W, Reichrath J. 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab. 2006;91(2):526\u20139.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"83_CR43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/joe.0.1640339","volume":"164","author":"N Akeno","year":"2000","unstructured":"Akeno N, Matsunuma A, Maeda T, Kawane T, Horiuchi N. Regulation of vitamin D-1alpha-hydroxylase and \u221224-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol. 2000;164(3):339\u201348.","journal-title":"J Endocrinol."},{"issue":"2","key":"83_CR44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jphotobiol.2010.04.001","volume":"101","author":"J Reichrath","year":"2010","unstructured":"Reichrath J. Dermatologic management, sun avoidance and vitamin D status in organ transplant recipients (OTR). J Photochem Photobiol B. 2010;101(2):150\u20139.","journal-title":"J Photochem Photobiol B."},{"issue":"12","key":"83_CR45","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/01.TP.0000065179.06731.99","volume":"75","author":"NK Briffa","year":"2003","unstructured":"Briffa NK, Keogh AM, Sambrook PN, Eisman JA. Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol. Transplantation. 2003;75(12):2133\u20134.","journal-title":"Transplantation."},{"issue":"5","key":"83_CR46","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1523-1755.2005.00306.x","volume":"67","author":"AE El-Agroudy","year":"2005","unstructured":"El-Agroudy AE, El-Husseini AA, El-Sayed M, Mohsen T, Ghoneim MA. A prospective randomized study for prevention of postrenal transplantation bone loss. Kidney Int. 2005;67(5):2039\u201345.","journal-title":"Kidney Int."},{"issue":"2","key":"83_CR47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-8278(00)00067-2","volume":"34","author":"H Isoniemi","year":"2001","unstructured":"Isoniemi H, Appelberg J, Nilsson CG, Makela P, Risteli J, Hockerstedt K. Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study. J Hepatol. 2001;34(2):299\u2013305.","journal-title":"J Hepatol"},{"issue":"4","key":"83_CR48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejon.2006.10.009","volume":"11","author":"KD Tierney","year":"2007","unstructured":"Tierney KD, Facione N, Padilla G, Blume K, Dodd M. Altered sexual health and quality of life in women prior to hematopoietic cell transplantation. Eur J Oncol Nurs. 2007;11(4):298\u2013308.","journal-title":"Eur J Oncol Nurs."},{"issue":"9","key":"83_CR49","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1445-5994.2006.01154.x","volume":"36","author":"AB D\u2019Souza","year":"2006","unstructured":"D\u2019Souza AB, Grigg AP, Szer J, Ebeling PR. Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation. Intern Med J. 2006;36(9):600\u20133.","journal-title":"Intern Med J."},{"issue":"10","key":"83_CR50","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","volume":"14","author":"M Coco","year":"2003","unstructured":"Coco M, Glicklich D, Faugere MC, Burris L, Bognar I, Durkin P, et al. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol. 2003;14(10):2669\u201376.","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"83_CR51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-144-4-200602210-00005","volume":"144","author":"BA Crawford","year":"2006","unstructured":"Crawford BA, Kam C, Pavlovic J, Byth K, Handelsman DJ, Angus PW, et al. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2006;144(4):239\u201348.","journal-title":"Ann Intern Med."},{"issue":"11","key":"83_CR52","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1359\/jbmr.2001.16.11.2111","volume":"16","author":"S Giannini","year":"2001","unstructured":"Giannini S, D\u2019Angelo A, Carraro G, Nobile M, Rigotti P, Bonfante L, et al. Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res. 2001;16(11):2111\u20137.","journal-title":"J Bone Miner Res."},{"issue":"8","key":"83_CR53","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMoa035617","volume":"350","author":"E Shane","year":"2004","unstructured":"Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, et al. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med. 2004;350(8):767\u201376.","journal-title":"N Engl J Med."},{"issue":"3","key":"83_CR54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00296-006-0196-2","volume":"27","author":"P Pennisi","year":"2007","unstructured":"Pennisi P, Trombetti A, Giostra E, Mentha G, Rizzoli R, Fiore CE. Pamidronate and osteoporosis prevention in liver transplant recipients. Rheumatol Int. 2007;27(3):251\u20136.","journal-title":"Rheumatol Int."},{"issue":"2","key":"83_CR55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s001980170142","volume":"12","author":"MA Krieg","year":"2001","unstructured":"Krieg MA, Seydoux C, Sandini L, Goy JJ, Berguer DG, Thiebaud D, et al. Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study. Osteoporos Int. 2001;12(2):112\u20136.","journal-title":"Osteoporos Int."},{"key":"83_CR56","doi-asserted-by":"crossref","unstructured":"Palmer SC, McGregor DO, Strippoli GF. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev. 2007(3):CD005015.","DOI":"10.1002\/14651858.CD005015.pub3"},{"issue":"1","key":"83_CR57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrneph.2009.192","volume":"6","author":"HH Malluche","year":"2010","unstructured":"Malluche HH, Monier-Faugere MC, Herberth J. Bone disease after renal transplantation. Nat Rev Nephrol. 2010;6(1):32\u201340.","journal-title":"Nat Rev Nephrol."},{"issue":"9","key":"83_CR58","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","volume":"8","author":"D Cejka","year":"2008","unstructured":"Cejka D, Benesch T, Krestan C, Roschger P, Klaushofer K, Pietschmann P, et al. Effect of teriparatide on early bone loss after kidney transplantation. Am J Transplant. 2008;8(9):1864\u201370.","journal-title":"Am J Transplant."},{"key":"83_CR59","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Stein EM, Ortiz D, Jin Z, McMahon DJ, Shane E. Prevention of Fractures after Solid Organ Transplantation: A Meta-Analysis. J Clin Endocrinol Metab. 2011 Aug 17. This is an important meta-analysis regarding the results from treatment with vitamin D and BPs after transplantation on the reduction of fractures.","DOI":"10.1210\/jc.2011-1448"},{"key":"83_CR60","doi-asserted-by":"crossref","unstructured":"Kulak CAM, Shane E: Transplantation Osteoporosis: biochemical Correlates of Pathogenesis and Treatment. In Dynamics of Bone and Cartilage Metabolism, 2nd edition. Edited by Seibel MJ, Robins SP, Bilezikian JP. Philadelphia: Elsevier; 2006:701\u2013716.","DOI":"10.1016\/B978-012088562-6\/50043-1"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-011-0083-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-011-0083-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-011-0083-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T16:18:38Z","timestamp":1742055518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-011-0083-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["83"],"URL":"https:\/\/doi.org\/10.1007\/s11914-011-0083-y","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}